This website uses functional cookies, including analytical cookies.
The obtained statistical data cannot be traced back to individual users.
Additionally, you can choose to accept or refuse consent to use marketing cookies.
If you decline these additional cookies or refrain from making a choice, only functional cookies will be set.
See our cookie policy for more information.
AkzoNobel recently announced that it's CEO Ton Büchner will be absent for a few weeks due to sick-leave. Probably this has scared investors. The author of this article, Cees van Riel, gives his view on the matter.
AkzoNobel recently announced that it's CEO Ton Büchner will be absent for a few weeks due to sick-leave. Probably this has scared investors. The author of this article, Cees van Riel, gives his view on the matter.
Participants
Cees
Role: Faculty
Reference type: Written by
Riel, C. van
Role: General
Reference type: Journalist